IS Pharma goes for growth
by Real Deals - Friday, 2nd May 2008 -
Chester-based medical devices business gets a major boost.
Bank of Scotland Corporate is to provide AIM-listed IS Pharma with a facility worth £8m (€10m) to fund the company’s continued growth and acquisition plans. IS Pharma is a late-stage pharmaceuticals and medical devices business in the specialist hospital medicine sector, with a current focus on critical care, neurology and oncology. The Chester-based company recently acquired Swiss pharmaceuticals group, Speciality European Pharmaceuticals, for £9.25m. IS Pharma, previously Maelor, adopted its new name following the acquisition, which has given it a new portfolio of specialist hospital pharmaceutical products.
WHAT NEXT?
Sign up for our newsletter and get our weekly pick of business news in your inbox!
Subscribe to our magazine for in depth interviews and advice from leading entrepreneurs!
Join our forum and talk business with other entrepreneurs!
Related tags: aim, growth, private equity, raising finance, medical, is pharma,
BUSINESS NEWS >>
By Rebecca Burn-Callander - July 03, 2009 11:28am GMT
By Rebecca Burn-Callander - July 02, 2009 4:43pm GMT
By Catherine Woods - July 02, 2009 4:33pm GMT
By Rebecca Burn-Callander - July 02, 2009 4:22pm GMT
By Catherine Woods - July 02, 2009 4:06pm GMT
BUSINESS COMMENT >>
By Catherine Woods - July 03, 2009 2:35pm GMT
By Rebecca Burn-Callander - July 01, 2009 1:12pm GMT
By Rebecca Burn-Callander - June 22, 2009 2:54pm GMT
By Rebecca Burn-Callander - June 12, 2009 12:16pm GMT
By Rebecca Burn-Callander - June 05, 2009 12:14pm GMT







